Skip to main content
. 2022 May 27;14(11):2662. doi: 10.3390/cancers14112662

Figure 2.

Figure 2

Individual tumor biology, within the limits of technical resectability, is more decisive for the tumor recurrence rate than mere morphometric criteria. Tumors with a low tumor burden but unfavorable tumor biology (arrow in light grey) may have worse outcome as compared to tumors with high tumor burden but favorable tumor biology (arrow in black).